Intermittent Hypoxemia and Risk for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension in Preterm Infants

Monday, April 25, 2022

8:30 AM – 8:45 AM US MT

Location: Convention Center: Mile High Ballroom 2C

CE: Enduring CME: 0.25

Publication Number: 3180.3

Samuel Gentle, UAB, Birmingham, AL, United States; Colm P. Travers, University of Alabama at Birmingham, Birmingham, AL, United States; Arie Nakhmani, University of Alabama at Birmingham, Birmingham, AL, United States; Premananda Indic, The University of Texas at Tyler, Tyler, TX, United States; Waldemar A. Carlo, University of Alabama at Birmingham, Birmingham, AL, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States

Presenting Author(s)

Samuel Gentle, MD
Assistant Professor
UAB
Birmingham, Alabama, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Samuel Gentle, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Colm P. Travers, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Arie Nakhmani, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Premananda Indic, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Waldemar A. Carlo, MD: ● Mednax (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Namasivayam Ambalavanan, MBBS MD: ● ProvePharm (Currently Ongoing) (Products/Services: Consultant).
● Radiometer (Currently Ongoing) (Products/Services: Consultant).
● ResBiotic (Currently Ongoing) (Products/Services: Advisory Committee).
● Shire (Currently Ongoing) (Products/Services: Consultant).